Skip to main content
Top
Published in: Archives of Virology 6/2012

01-06-2012 | Brief Report

Persistent and recrudescent infection in cattle following natural infection with Middle Point orbivirus

Authors: Christopher Cowled, Lorna Melville, Richard Weir, Susan Walsh, Aneta Gubala, Steven Davis, David Boyle

Published in: Archives of Virology | Issue 6/2012

Login to get access

Abstract

Middle Point orbivirus (MPOV) is a recently described Australian arbovirus, related to Yunnan orbivirus from China. Analysis of genetic variation within the major serotype gene of MPOV isolates collected from sentinel cattle has identified eight co-circulating strains. The pattern of strain isolation from individual animals during the study period was consistent with an interpretation of persistent MPOV infection of up to five months, featuring episodes of quiescence (below levels required for virus isolation) followed by viral recrudescence. This is significant with regard to current interpretations of infection, persistence and recrudescence during natural infections of orbiviruses, including bluetongue virus.
Appendix
Available only for authorised users
Literature
3.
go back to reference Lunt RA, Melville L, Hunt N, Davis S, Rootes CL, Newberry KM, Pritchard LI, Middleton D, Bingham J, Daniels PW, Eaton BT (2006) Cultured skin fibroblast cells derived from bluetongue virus-inoculated sheep and field-infected cattle are not a source of late and protracted recoverable virus. J Gen Virol 87:3661–3666. doi:10.1099/vir.0.81653-0 PubMedCrossRef Lunt RA, Melville L, Hunt N, Davis S, Rootes CL, Newberry KM, Pritchard LI, Middleton D, Bingham J, Daniels PW, Eaton BT (2006) Cultured skin fibroblast cells derived from bluetongue virus-inoculated sheep and field-infected cattle are not a source of late and protracted recoverable virus. J Gen Virol 87:3661–3666. doi:10.​1099/​vir.​0.​81653-0 PubMedCrossRef
4.
go back to reference Luedke AJ, Jones RH, Walton TE (1977) Overwintering mechanism for bluetongue virus: biological recovery of latent virus from a bovine by bites of Culicoides variipennis. Am J Trop Med Hyg 26:313–325PubMed Luedke AJ, Jones RH, Walton TE (1977) Overwintering mechanism for bluetongue virus: biological recovery of latent virus from a bovine by bites of Culicoides variipennis. Am J Trop Med Hyg 26:313–325PubMed
6.
go back to reference Katz J, Alstad D, Gustafson G, Evermann J (1994) Diagnostic analysis of the prolonged bluetongue virus RNA presence found in the blood of naturally infected cattle and experimentally infected sheep. J Vet Diagn Invest 6:139–142. doi:10.1177/104063879400600201 PubMedCrossRef Katz J, Alstad D, Gustafson G, Evermann J (1994) Diagnostic analysis of the prolonged bluetongue virus RNA presence found in the blood of naturally infected cattle and experimentally infected sheep. J Vet Diagn Invest 6:139–142. doi:10.​1177/​1040638794006002​01 PubMedCrossRef
7.
go back to reference MacLachlan NJ, Nunamaker RA, Katz JB, Sawyer MM, Akita GY, Osburn BI, Tabachnick WJ (1994) Detection of bluetongue virus in the blood of inoculated calves: comparison of virus isolation, PCR assay, and in vitro feeding of Culicoides variipennis. Arch Virol 136:1–8. doi:10.1007/BF01538812 PubMedCrossRef MacLachlan NJ, Nunamaker RA, Katz JB, Sawyer MM, Akita GY, Osburn BI, Tabachnick WJ (1994) Detection of bluetongue virus in the blood of inoculated calves: comparison of virus isolation, PCR assay, and in vitro feeding of Culicoides variipennis. Arch Virol 136:1–8. doi:10.​1007/​BF01538812 PubMedCrossRef
9.
go back to reference Cowled C, Melville L, Weir R, Walsh S, Hyatt A, Van Driel R, Davis S, Gubala A, Boyle D (2007) Genetic and epidemiological characterization of Middle Point orbivirus, a novel virus isolated from sentinel cattle in northern Australia. J Gen Virol 88:3413–3422. doi:10.1099/vir.0.83231-0 PubMedCrossRef Cowled C, Melville L, Weir R, Walsh S, Hyatt A, Van Driel R, Davis S, Gubala A, Boyle D (2007) Genetic and epidemiological characterization of Middle Point orbivirus, a novel virus isolated from sentinel cattle in northern Australia. J Gen Virol 88:3413–3422. doi:10.​1099/​vir.​0.​83231-0 PubMedCrossRef
10.
go back to reference Attoui H, Mohd Jaafar F, Belhouchet M, Aldrovandi N, Tao S, Chen B, Liang G, Tesh RB, de Micco P, de Lamballerie X (2005) Yunnan orbivirus, a new orbivirus species isolated from Culex tritaeniorhynchus mosquitoes in China. J Gen Virol 86:3409–3417. doi:10.1099/vir.0.81258-0 PubMedCrossRef Attoui H, Mohd Jaafar F, Belhouchet M, Aldrovandi N, Tao S, Chen B, Liang G, Tesh RB, de Micco P, de Lamballerie X (2005) Yunnan orbivirus, a new orbivirus species isolated from Culex tritaeniorhynchus mosquitoes in China. J Gen Virol 86:3409–3417. doi:10.​1099/​vir.​0.​81258-0 PubMedCrossRef
11.
12.
go back to reference Potgieter AC, Cloete M, Pretorius PJ, van Dijk AA (2003) A first full outer capsid protein sequence data-set in the Orbivirus genus (family Reoviridae): cloning, sequencing, expression and analysis of a complete set of full-length outer capsid VP2 genes of the nine African horse sickness virus serotypes. J Gen Virol 84:1317–1326. doi:10.1099/vir.0.18919-0 PubMedCrossRef Potgieter AC, Cloete M, Pretorius PJ, van Dijk AA (2003) A first full outer capsid protein sequence data-set in the Orbivirus genus (family Reoviridae): cloning, sequencing, expression and analysis of a complete set of full-length outer capsid VP2 genes of the nine African horse sickness virus serotypes. J Gen Virol 84:1317–1326. doi:10.​1099/​vir.​0.​18919-0 PubMedCrossRef
Metadata
Title
Persistent and recrudescent infection in cattle following natural infection with Middle Point orbivirus
Authors
Christopher Cowled
Lorna Melville
Richard Weir
Susan Walsh
Aneta Gubala
Steven Davis
David Boyle
Publication date
01-06-2012
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 6/2012
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-012-1277-z

Other articles of this Issue 6/2012

Archives of Virology 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine